Chronotherapy of high-dose 1,25- dihydroxyvitamin D3 in hemodialysis patients with secondary hyperparathyroidism: A single-dose study

Clinical Pharmacology and Therapeutics

Volumn 66, Issue 6, 1999, Pages 609-616

  Tsuruoka, Shuichi ^a   Sugimoto, Koh Ichi ^b   Ohmori, Masami ^b   Kawaguchi, Atsuhiro ^b   Saito, Tetsuo ^b   Fujimura, Akio ^b  

^a JICHI MEDICAL UNIVERSITY   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CALCITRIOL; CALCIUM; COLECALCIFEROL; PARATHYROID HORMONE; PHOSPHATE;

ADULT; ARTICLE; CALCIUM BLOOD LEVEL; CHRONIC KIDNEY FAILURE; CHRONOTHERAPY; CIRCADIAN RHYTHM; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG MEGADOSE; DRUG METABOLISM; FEMALE; HEMODIALYSIS; HUMAN; HYPERCALCEMIA; PARATHYROID HORMONE BLOOD LEVEL; PHOSPHATE BLOOD LEVEL; PRIORITY JOURNAL; SECONDARY HYPERPARATHYROIDISM; TREATMENT OUTCOME; VITAMIN BLOOD LEVEL;

EID: 0033395159     PISSN: 00099236     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0009-9236(99)90070-x     Document Type: Article

References (22)

1. 1. Llach F, Bover J. Renal osteodystrophy. In: Brenner B, editor. Brenner and Rector's the kidney. Philadelphia: WB Saunders; 1996. p. 2187-273.
2. 2. Slatopolsky E, Weerts C, Thielan J, Horst R, Harter H, Martin KJ. Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxy-cholecalciferol in uremic patients. J Clin Invest 1984;74:2136-43.
3. 3 pulse therapy in hemodialysis patients with severe secondary hyperparathyroidism. Nephron 1991;57:23-8.
4. 4. Fukagawa M, Okazaki R, Takano K, Kaname S, Ogata E, Kitaoka M, et al. Regression of parathyroid hyperplasia by calcitriol-pulse therapy in patients on long-term dialysis [letter]. N Engl J Med 1990;323:421-2.
5. 5. Calvo NS, Eastell R, Offord KP, Bergstralh EJ, Burritt MP. Circadian variation in ionized calcium and intact parathyroid hormone: Evidence for sex differences in calcium homeostasis. J Clin Endocrinol Metab 1991;72:69-76.
6. 6. el-Hajj Fuleihan G, Klerman EB, Brown EN, Choe Y, Brown EM, Czeisler, CA. The parathyroid hormone circadian rhythm is truly endogenous - a general clinical research center study. J Clin Endocrinol Metab 1997; 82:281-6.
7. 7. Shinoda H, Seto H. Diurnal rhythms in calcium and phosphate metabolism in rodents and their relations to lighting and feeding schedules. Miner Electrolyte Metab 1985;11:158-66.
8. 8. Schaefer K, Umlauf E, von HD. Reduced risk of hypercalcemia for hemodialysis patients by administering calcitriol at night. Am J Kidney Dis 1992;19:460-4.
9. 9. Connerty HV, Briggs AR. Determination of serum calcium by means of orthocresolphtalein complexone. Am J Clin Pathol 1966;45:290-6.
10. 10. Drewes P. Direct colorimetric determination of phosphorus in serum and urine. Clin Chim Acta 1972;39:81-8.
11. 11. Frolich M, Walma ST, Paulson C, Papapoulos SE. Immunoradiometric assay for intact human parathyroid hormone: characteristics, clinical application and comparison with a radioimmunoassay. Ann Clin Biochem 1990;27(Pt 1):69-72.
12. 12. Fraser WD, Durham BH, Berry JL, Mawer EB. Measurement of plasma 1,25 dihydroxyvitamin D using a novel immunoextraction technique and immunoassay with iodine labelled vitamin D tracer. Ann Clin Biochem 1997;34(Pt 6):632-7.
13. 3 of transcription of pre-proparathyroid hormone gene. Endocrinology 1986;119:2864-6.
14. 3-mediated intestinal calcium transport: biochemical identification of lysosomes containing calcium and calcium-binding protein (calbindin-D28K). J Biol Chem 1986;261:16106-14.
15. 3 stimulates rat osteoblastic cells to release a soluble factor that increases osteoclastic bone resorption. J Clin Invest 1987;80:425-9.
16. 16. Lemmer B, Scheidel B, Behne S. Chronopharmacokinetics and chronopharmacodynamics of cardiovascular active drugs: propranolol, organic nitrates, nifedipine. Ann NY Acad Sci 1991;618:166-81.
17. 17. Prins J, Weverling G, van Katel R, Speelman P. Circadian variation in serum levels and the renal toxicity of aminoglycosides in patients. Clin Pharmacol Ther 1997;62:106-11.
18. 18. Wrobel J. Development of circadian variations in intestinal calcium transport during maturation of the rat. Acta Physiol Pol 1981;32:407-17.
19. 19. Kishikawa T, Takahashi H, Shimazawa E, Ogata E. Diurnal changes in calcium and phosphate metabolism in rats. Horm Metab Res 1980;12:545-51.
20. 20. Silver R, Romero MT, Besmer HR, Leak R, Nunez JM, LeSauter J. Calbindin-D28K cells in the hamster SCN express light-induced Fos. Neuroreport 1996;7:1224-8.
21. 21. Sweny P. Optimum route of administration of vitamin D in renal failure. Nephrol Dial Transplant 1995;4:29-32.
22. 22. Shinoda H. Diurnal rhythms in calcium metabolism in rats and their relations to the effect of blockers of bone resorption. In: Ogura H, editor. Pharmacological approach to the study of the formation and resorption mechanism of hard tissue. St Louis: Ishiyaku EuroAmerica; 1994. p. 43.